Literature DB >> 14568839

Imiquimod: a topically applied link between innate and acquired immunity.

Daniel J Hurwitz1, Laura Pincus, Thomas S Kupper.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14568839     DOI： 10.1001/archderm.139.10.1347

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  10 in total

1.  TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway.

Authors:  Jason Z Oh; Jonathan S Kurche; Matthew A Burchill; Ross M Kedl
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

2.  Imiquimod-induced TLR7 signaling enhances repair of DNA damage induced by ultraviolet light in bone marrow-derived cells.

Authors:  Rita Fishelevich; Yuming Zhao; Papapit Tuchinda; Hannah Liu; Ayako Nakazono; Antonella Tammaro; Tzu-Ching Meng; Jim Lee; Anthony A Gaspari
Journal:  J Immunol       Date:  2011-07-15       Impact factor: 5.422

3.  Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes.

Authors:  Terry H Wu; Karin Schreiber; Ainhoa Arina; Nikolai N Khodarev; Elena V Efimova; Donald A Rowley; Ralph R Weichselbaum; Hans Schreiber
Journal:  Cancer Immun       Date:  2011-06-30

Review 4.  Immunopathogenesis and therapy of cutaneous T cell lymphoma.

Authors:  Ellen J Kim; Stephen Hess; Stephen K Richardson; Sara Newton; Louise C Showe; Bernice M Benoit; Ravi Ubriani; Carmela C Vittorio; Jacqueline M Junkins-Hopkins; Maria Wysocka; Alain H Rook
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 5.  Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review.

Authors:  Inga Neumann; R Patalay; M Kaushik; H Timlin; C Daniel
Journal:  Eye (Lond)       Date:  2022-07-14       Impact factor: 4.456

6.  Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.

Authors:  Susan J Huang; Dirkjan Hijnen; George F Murphy; Thomas S Kupper; Adam W Calarese; Ilse G Mollet; Carl F Schanbacher; Danielle M Miller; Chrysalyne D Schmults; Rachael A Clark
Journal:  J Invest Dermatol       Date:  2009-06-11       Impact factor: 8.551

7.  Effects of imiquimod and low-intensity laser (λ660 nm) in chemically induced oral carcinomas in hamster buccal pouch mucosa.

Authors:  Juliana S de C Monteiro; Susana C P S de Oliveira; João Alves Reis Júnior; Clarissa Araújo Silva Gurgel; Suzana C O Machado de Souza; Antônio Luiz Barbosa Pinheiro; Jean Nunes dos Santos
Journal:  Lasers Med Sci       Date:  2012-09-01       Impact factor: 3.161

8.  Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.

Authors:  Monica C Panelli; Mitchell E Stashower; Herbert B Slade; Kina Smith; Christopher Norwood; Andrea Abati; Patricia Fetsch; Armando Filie; Shelley-Ann Walters; Calvin Astry; Eleonora Aricó; Yingdong Zhao; Silvia Selleri; Ena Wang; Francesco M Marincola
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

9.  Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets.

Authors:  Ping Jin; Ena Wang; Maurizio Provenzano; Sara Deola; Silvia Selleri; Jiaqiang Ren; Sonia Voiculescu; David Stroncek; Monica C Panelli; Francesco M Marincola
Journal:  J Transl Med       Date:  2006-06-28       Impact factor: 5.531

10.  Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells.

Authors:  Rachael A Clark; Susan J Huang; George F Murphy; Ilse G Mollet; Dirkjan Hijnen; Manoj Muthukuru; Carl F Schanbacher; Vonetta Edwards; Danielle M Miller; Jenny E Kim; Jo Lambert; Thomas S Kupper
Journal:  J Exp Med       Date:  2008-09-15       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.